Direct contact between AML cells and NK cells, high expression of CD200 on AML cells, soluble NKG2D ligands (NKG2DLs) in the sera and suppressive tumor microenvironment are factors that lead to defective receptor expression changes [49, 53, 54]. The gene discussed is KLRK1; the disease is acute myeloid leukemia.